Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Late-Stage Pipeline

50%

2 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

Phase 4
2(50.0%)
Phase 2
1(25.0%)
N/A
1(25.0%)
4Total
Phase 4(2)
Phase 2(1)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07295938Phase 2Recruiting

TCM as an Adjuvant Treatment in Mycobacterium Abscessus Pulmonary Disease

Role: collaborator

NCT07213765Phase 4Recruiting

Short-term Antibiotic Therapy in Mycobacterium Avium Complex Pulmonary Disease

Role: collaborator

NCT07174076Phase 4Recruiting

Prevention of Recurrence With Cordyceps Sinensis in Mycobacterium Avium Complex Pulmonary Disease

Role: collaborator

NCT05248022Not ApplicableUnknown

Efficacy and Safety of DEB-BACE Combined With PD-1 Inhibitors in Stage II/III NSCLC With Standard Treatment Failure

Role: collaborator

All 4 trials loaded